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5-HYDROXYMETHYLCYTOSINE IS A KEY EPIGENETIC REGULATOR OF 
KERATINOCYTE STEM CELLS DURING PSORIASIS PATHOGENESIS 
CHRISTINE WAN-YIN YUAN 
ABSTRACT 
 Epigenetic regulation is now known to play an important role in determining stem 
cell fate during normal tissue development and disease pathogenesis. In this study, we 
report loss of 5-hydroxymethylcytosine (5-hmC) mediated by ten-eleven translocation 
(TET) methylcytosine dioxygenases in keratinocyte stem cells (KSCs) and in their 
progenitor transit-amplifying (TA) cells of psoriatic lesions. We establish the DNA 
hydroxymethylation profile in both human psoriasis as well as in the imiquimod (IMQ)-
induced mouse psoriasis model. Genome-wide mapping of 5-hmC in IMQ-treated mice 
epithelium revealed a loci-specific reduction of 5-hmC in genes associated with 
maintaining stem cell homeostasis including those involved in the RAR and Wnt/β-
catenin signaling pathways. Restoration of TET expression in human KSC cultures via 
vitamin C treatment increased 5-hmC levels and induced more normal KSC 
differentiation. We found that by modulating 5-hmC levels in vitro, we could alter 
downstream expression of genes important in regulating stem cell homeostasis like nestin 
as well as IL-17R known to promote the psoriatic phenotype. Our findings demonstrate 
that loss of 5-hmC is a critical epigenomic phenomenon in KSCs and TA cells during 
psoriasis pathogenesis. 
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INTRODUCTION 
 
Psoriasis is a common chronic autoimmune skin disease that affects 3.2% of the 
US population and is prevalent worldwide. Patients with psoriasis have disfiguring 
erythematous scaly plaques on the skin surface that often relapse even after successful 
treatment (Carey et al., 2006; Nestle et al., 2009). Treatment of psoriasis along with 
management of psychological distress and social consequences of the disease result in 
costs of around $135 billion annually in the US (Brezinski, Dhillon, & Armstrong, 2015). 
Psoriatic disease extends beyond the skin and is associated with several comorbidities 
including inflammatory bowel disease, uveitis, psychiatric disorders, metabolic 
syndrome, chronic obstructive pulmonary disease, obstructive sleep apnea, osteoporosis, 
and cardiovascular factors (Machado-Pinto, Diniz, & Bavoso, 2016). Theories of 
psoriasis pathogenesis suggest interplay of aberrant genetic and epigenetic patterns as 
well as immune and environmental factors (Chandran & Raychaudhuri, 2010). However, 
after decades of research the root cause of psoriasis remains unknown. 
The histopathology of psoriasis presents with parakeratosis, hypogranulosis, 
infiltration by neutrophils, increased dermal angiogenesis, and acanthosis with downward 
expansion of the rete ridges (Chandra, Senapati, Roy, Chatterjee, & Chatterjee, 2018; 
Ozkanli et al., 2015). At the tips of these rete ridges, there are keratinocyte stem cells 
(KSCs) that undergo asymmetric division with one cell retaining stemness and another 
cell that eventually undergoes terminal differentiation into keratinocytes, called transit 
amplifying (TA) cells (Saldanha, Royston, Udayakumar, & Tollefsbol, 2015; Waseem et 
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al., 1999). These TA cells are located in the suprabasal layer of the skin and can 
orchestrate stem cell activity by inducing SHH-dependent KSC proliferation (Hsu, Li, & 
Fuchs, 2014). In psoriasis, disruption of KSC homeostasis results in extensive 
proliferation and aberrant differentiation of KSCs causing benign epidermal hyperplasia 
(Jia et al., 2016; Weatherhead et al., 2011). Epidermal turnover time in normal skin is 27 
days with cell cycles lasting 311 hrs, while psoriatic epidermal turnover time is 4 days 
with a shorted cell cycle time of 36 hrs (Watarai, Amoh, Maejima, Hamada, & Katsuoka, 
2013).  
Asymmetric stem cell divisions are increased in an interleukin-17A (IL-17A) 
dependent manner in psoriasis, which suggests immune regulation of keratinocyte 
hyperproliferation (Charruyer et al., 2017). Initiation of keratinocyte proliferation and 
entry of quiescent stem cells into the cell cycle can lead to the loss of KSC immune 
evasion and promotion of proinflammatory effects (Agudo et al., 2018). The IL-23/IL-
17A axis is thought to be critical in psoriasis pathogenesis by acting on different cellular 
targets including keratinocytes, endothelial cells, and innate immune cells (Blauvelt & 
Chiricozzi, 2018; van der Fits et al., 2009). Studies have shown that IL-17 can promote 
increased proliferation and aberrant differentiation of keratinocytes through REG3A or 
by downregulating genes involved in keratinocyte differentiation like filaggrin 
(Gutowska‐Owsiak et al., 2012; Lai et al., 2012). KSCs have also been shown to be 
capable of developing inflammatory memory that leads to a heightened proliferative 
response to subsequent immune stressors as seen in recurrent psoriasis (Clark, 2011; Naik 
et al., 2017). These studies demonstrate that KSCs and TA cells are key players in 
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psoriasis pathogenesis and suggest crosstalk between the psoriatic epidermis and immune 
factors.  
Recent studies have shown the importance of epigenetics in autoimmune diseases 
like psoriasis (Lu, 2013). Genome-wide methylation studies have identified aberrant 
DNA methylation sites that are associated with unique histopathological features in 
psoriatic lesions as well as with altered gene expression in psoriasis (Chandra et al., 2018; 
Zhou et al., 2016). Patients who exhibited clinical improvement of their psoriasis from 
anti-TNF-α therapy or UVB phototherapy showed loci-specific restoration to a more 
normal methylation status (Gu, Nylander, Coates, Fahraeus, & Nylander, 2015; Roberson 
et al., 2012). Overall there seems to be a positive correction between global DNA 
methylation level and psoriasis area and severity index (PASI) scores among psoriasis 
patients (P. Zhang, Su, Chen, Zhao, & Lu, 2010).  
We now know that the DNA methylation landscape can be modulated by 
dioxygenases from the ten-eleven translocation (TET) family through the conversion of 
genomic 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC), 5-
formylcytosine (5-fC), and 5-carboxylcytosine (5-caC) (Ito et al., 2011). These oxidized 
5-mc derivatives are stable epigenetic modifications that act as intermediates in the DNA 
demethylation pathway and can further regulate gene expression (An, Rao, & Ko, 2017). 
The dynamic balance between methylation and demethylation is essential because 5-hmC 
can modulate transcription patterns by recruiting a different set of DNA binding proteins 
compared to 5-mC (Gustafson et al., 2015). 5-hmC levels are usually higher than 5-fC 
and 5-caC levels showing that this TET-catalyzed oxidation pathway is often stalled at 5-
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hmC (An et al., 2017; Kohli & Zhang, 2013). Following active modification of 5-mC to 
5-hmC in the demethylation pathway, 5-hmC can either be passively depleted or actively 
restored to unmodified cytosine. Passive depletion of 5-hmC is accomplished through 
DNA replication, while active restoration of cytosine requires iterative oxidation and 
thymine DNA glycosylase-mediated base excision repair (An et al., 2017).  
The three known mammalian TET isozymes (TET1, TET2, and TET3) are 
dioxygenases dependent on molecular oxygen, Fe2+, and 2-oxoglutarate for their activity 
(Kohli & Zhang, 2013). 2-oxoglutarate is mainly produced in the TCA cycle by isocitrate 
dehydrogenase (IDH) 1 and 2 (An et al., 2017). A recent study associated loss of 5-hmC 
with downregulation of IDH2 and decreased TET2 activity in melanoma (Lian et al., 
2012). Furthermore, IDH2 overexpression reestablished the 5-hmC landscape thereby 
suppressing melanoma growth and increasing tumor-free survival in animal models (Lian 
et al., 2012). Vitamin C also plays a crucial role by reducing oxidized iron species back 
to catalytically active Fe2+ needed to maintain full enzymatic capacity of TET (Cimmino 
et al., 2017; Gustafson et al., 2015; Sant et al., 2018). Vitamin C treatment of 
hematopoietic stem and progenitor cells (HSPC) from TET2-deficient mice resembled 
TET2 restoration and reversed the DNA hypermethylation phenotype (Cimmino et al., 
2017). Induction of the demethylation pathway in HSPCs suppressed human leukemic 
colony formation and leukemia progression in primary human leukemia patient-derived 
xenografts (Cimmino et al., 2017). Furthermore, increased TET2 expression promoted 
normal cellular differentiation and blocked aberrant HSPC self-renewal seen in leukemia 
(Cimmino et al., 2017). TET enzymes are also highly expressed in embryonic stem cells 
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where knockout of TET enzymes can lead to downregulation pluripotency-related genes 
(Ficz et al., 2011). Taken together, DNA hydroxymethylation seems to play an important 
role in hyperproliferative disease pathogenesis as well as in regulating stem cell 
differentiation. Thus, we wondered if 5-hmC levels might also influence 
hyperproliferative KSCs in psoriatic lesions.  
In this present study, we hope of shed some light on the etiology of psoriasis by 
investigating the 5-hmC landscape in KSCs and TA cells during psoriasis pathogenesis. 
These cell populations were tracked using cytokeratin 15 (CK15) to mark KSCs in the 
epidermal basal layer and fatty acid binding protein 5 (FABP5) to label TA cells in the 
suprabasal epidermis (Watarai et al., 2013; Whitbread & Powell, 1998).We first looked at 
clinical cases of human psoriasis and saw epidermal loss of 5-hmC in our 
immunofluorescence stains. To confirm these findings, we used a highly relevant 
imiquimod (IMQ)-induced psoriasis mouse model for further investigation. Both the 
histopathological manifestations of IMQ-induced psoriasis and 5-hmC levels in the 
psoriatic epidermis were similar to that of clinical psoriasis cases. Quantitative real-time 
PCR analyses suggested that the loss of 5-hmC was due to decreased TET enzyme 
expression. In addition, characterization of KSCs and TA cells in human and IMQ-treated 
mouse showed depletion of the KSC population as the TA cell compartment expanded. 
To see whether 5-hmC could regulate gene expression related to cell differentiation, we 
also looked at nestin expression levels in humans and mice. Interestingly, we found that 
nestin levels inversely correlated with 5-hmC levels in psoriatic epidermis, which 
supported similar findings in melanoma (Gomes et al., 2016). Genome-wide mapping of 
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5-hmC using hydroxymethylated DNA immunoprecipitation coupled with high-
throughput sequencing (hMeDIP-seq) allowed us to find loci-specific loss of 5-hmC that 
could alter gene expression and pathways associated with characteristic 
hyperproliferation and aberrant differentiation of stem cells. Vitamin C treatment of 
KSCs in calcium-induced differentiation and proliferation assays revealed that induction 
of TET activity could restore 5-hmC levels and modulate nestin expression. This study 
shows that DNA hydroxymethylation in KSCs and TA cells plays an important role 
during psoriasis pathogenesis and suggests potential for a new strategy for epigenetic 
psoriasis therapy. 
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METHODS 
 
Immunofluorescence staining 
All human tissue samples were provided by the Dermatology department of 
Brigham and Women’s Hospital. Keratinocyte stem cells for in vitro experiments were 
provided by the Cutaneous Biology Research Center at Massachusetts General Hospital. 
Immunofluorescence (IF) stains were performed on paraffin-embedded sections of 
formalin-fixed tissue samples and 4% paraformaldehyde (Electron Microscopy Sciences, 
Hatfield, PA) fixed KSCs. Tissue sections were deparaffinized, rehydrated, and then 
heated with Target Antigen Retrieval Solution (Dako) in a pressure cooker for 40 min. 
Fixed cell culture samples were permeabilized using 0.5% TritonX-100 (Sigma) and 
incubated with 4 N HCl for 30 min for 5-hmC staining. Samples were blocked with 10% 
animal serum for 30 min to 1 hour prior to incubation with respective primary antibodies. 
Samples were incubated with the following primary antibodies at 4°C overnight: rabbit 
IgG-anti-5hmC (1:2000; Active Motif), mouse IgG2a-anti-CK15 (1:100; Thermo 
Scientific), mouse IgG1-anti-nestin (1:800; Millipore), or rabbit IgG-anti-FABP5 (1:600; 
Cell Signaling). In order to reduce autofluorescence in tissue samples, sections were 
blocked with 0.1% Sudan Black (Abcam, UK) for 10 min. Sections were then incubated 
with the following secondary antibodies for 1 hour in room temperature: AF488 goat-
anti-rabbit (1:2000; Invitrogen), AF546 goat-anti-mouse IgG1 (1:2000, Vector 
Laboratories), goat-anti-rabbit Biotin (1:2000, ThermoFisher), or rat-anti-mouse IgG1 
Biotin (1:100, Bioscience). Biotinylated secondary antibodies were further processed 
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with Strep AF647 Biotin (1:1000, ThermoFisher) for 30 min. Cell nuclei were labeled 
with DAPI (Invitrogen, Carlsbad, CA).  
 
Immunohistochemistry staining 
Immunohistochemistry (IHC) staining was done on paraffin-embedded sections of 
formalin-fixed mouse tissue. Mouse tissue sections were first deparaffinized, rehydrated, 
and blocked with 3% peroxide. Heat-induced antigen retrieval was done in a pressure 
cooker using Target Antigen Retrieval solution (Dako, Carpinteria, CA). Sections were 
blocked with 10% animal serum for 30 min before incubation with primary antibodies. 
Sections were incubated with the following primary antibodies at 4°C overnight: rabbit 
IgG-anti-5hmC (1:2000; Active Motif), mouse IgG2a-anti-CK15 (1:100; Thermo 
Scientific), mouse IgG1-anti-nestin (1:800; Millipore), or rabbit IgG-anti-FABP5 (1:600; 
Cell Signaling). For double labeled samples, simultaneous staining was performed for 5-
hmC/CK15 and 5-hmC/nestin. However, due to secondary antibody specificity, 
sequential staining was necessary for 5-hmC/FABP5 double labeled sections. Sections 
were incubated with the following secondary antibodies for 1 hour in room temperature: 
horse-anti-mouse HRP, goat-anti-rabbit HRP, mouse polymer HRP, horse-anti-mouse 
AP, or donkey-anti-rabbit AP. They were then processed by one of the following: DAB + 
Chromagen (Dako), Vector Red Alkaline Phosphatase (Vector Laboratories), Vector 
NovaRed (Vector Laboratories), Vector Blue Alkaline Phosphatase (Vector 
Laboratories), or ImmPRESS-AP anti-mouse IgG polymer detection kit (Vector 
Laboratories). Samples were counterstained using Gill’s Hematotoxylin (Fisher 
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Scientific, Kalamazoo, MI) and treated with Defining Solution (Fisher Scientific, 
Kalamazoo) and Bluing Solution (American MasterTech Scientific). Hematotoxylin and 
eosin stains were done by Harvard Medical Area Core Management System, Rodent 
Histopathology. 
 
Mice and Epidermal Isolation 
C57BL/6J mice were treated under defined conditions in accordance with 
institutional guidelines. Experiments were executed according to approved experimental 
protocols. 6-week-old mice received a topical daily dose of 62.5 μg of Aldara 5% cream 
(Aldara, 3M Pharmaceuticals) onto their shaved back and right ear for six consecutive 
days. This is equivalent to a daily dose of 3.125 mg of the active compound. Control 
mouse skin was treated in the same conditions with Vaseline as a control vehicle cream. 
Punch biopsies were taken from the mice after 6 consecutive days of IMQ treatment and 
used for IHC studies. Separation and isolation of the epidermis from shave biopsies of the 
mice were also taken for real-time PCR and hMeDIP-seq experiments. Separation of the 
epidermis from the dermis was accomplished by soaking epidermal samples in 0.2% 
dispase in 4°C for 6 hours and then manually pulling epidermis apart from the dermis. 
 
Hydroxymethylated DNA Immunoprecipitation with High Throughput Sequencing 
Genomic DNA from the isolated epidermis of mice were first purified, sonicated, 
and ligated with Illumina barcode adapters prior to hydroxymethylated DNA 
immunoprecipitation with high throughput sequencing (hMeDIP-seq). Adaptor-ligated 
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DNA (5 μg) was denatured and incubated overnight with 3 μL of 5-hmC antibody 
(Active Motif) at 4°C. Protein A/G beads were used to capture the antibody-DNA 
complexes. 5-hmC immunoprecipitated DNA was purified and sequenced using the 
Illumina platform and standard Illumina protocols (Xu et al., 2011). Read sequences were 
aligned to mouse genome (mm10) using ELAND v2 in the CASAVA (Illumina, v1.6) 
package. We used MACS2 to identify differentially hydroxymethylated genes (Yong 
Zhang et al., 2008). Gene Ontology was used for pathway analysis and Ingenuity 
Pathway Analysis for network analysis (Ashburner et al., 2000; Krämer, Green, Pollard, 
& Tugendreich, 2014). 
 
Quantitative RT-PCR 
Quantitative real-time PCR was performed for human KSC cultures as well as 
isolated epidermal samples from the ear and back skin of sacrificed mice. Total mRNA 
was extracted using the RNeasy® mini kit (Qiagen). The concentration of RNA was 
measured by a NanoDrop spectrophotometer (Thermo Fisher). With 1 μg of purified 
RNA from epithelium, 1 μL of cDNA was made using the T100TMPCR system (Bio-
Rad). These cDNA products combined with forward and reverse primer mixes for the 
following target genes: TET1, TET2, nestin, and IL-17RA (Table 1). For each sample, 
1µl cDNA was mixed with 10 µl Power SYBR® Green Master Mix (Bio Rad) and 8µl 
RNase-Free water containing 1 µl forward and reverse primer mixes. Quantitative real-
time polymerase chain reaction (RT-PCR) was performed using the CFX96 real-time 
PCR detection system (Bio-Rad) with Bio-Rad CFX manager software (Bio-Rad). Target 
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gene mRNA levels were calculated relative to GAPDH mRNA levels to normalize for 
RNA input. The ΔΔCt method was used to calculate the fold-change in RNA levels. 
Table 1. Quantitative real-time PCR Primers 
Gene Forward (5’ → 3’) Reverse (3’→ 5’) 
mTET1 AACAAGAGGCCCCAGAG TTCTTCCCCATGACCAC 
mTET2 AGAGAAGACAATCGAGAAGTCGG CCTTCCGTACTCCCAAACTCAT 
mNestin CTTTCCTGACCCCAAGCTGA CTGAGGACCAGGACTCTCTA 
mIL17R TCCAGAAGGCCCTCAGACTA CTCGACCCTGAAAGTGAAGG 
hTET2 CAGCACATTGGTATGCACTC TTTCCTTTGTCGGCAAGTCT 
hNestin AGAGGGGAATTCCTGGAG CTGAGGACCAGGACTCTCTA 
hIL17R TGTCCACCATGTGGCCTAAGAG GTCCGAAATGAGGCTGTCTTTGA 
 
Human Keratinocyte Stem Cell Culture 
Human keratinocyte stem cells obtained from neonatal foreskin were given by the 
Cutaneous Biology Research Center at Massachusetts General Hospital. 5.0 × 104 cells 
were plated in 6cm plastic dishes. KSCs were cultured in EpiLife Calcium-Free MEPICF 
cell culture medium (Cascade Biologics, Carlsbad, CA) and incubated at 37°C, 5% CO2 
for 24 hrs. prior to addition of calcium. Cultures were then treated with either 1.5mM Ca2 
(normal calcium) or 0.06mM Ca2+ (low calcium). After 24 hours of incubation with 
calcium, select cultures were treated with 200μmol/L vitamin C using L-Ascorbic Acid 
(Thermo Fisher) for 48 hrs. The cultures were then harvested for immunofluorescence 
studies or real-time PCR. 
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RESULTS 
 
Clinical psoriasis cases show loss of 5-hmC in basal and suprabasal keratinocytes 
We performed immunofluorescence (IF) stains to analyze KSC DNA 
hydroxymethylation in 13 clinical psoriasis cases in comparison to 10 clinical cases of 
another chronic psoriasiform dermatoses, lichen simplex chronicus (LSC). Another 10 
cases of normal skin were also used as controls. Significant loss of 5-hmC can be seen in 
both basal and suprabasal keratinocytes of psoriatic epidermis compared to that of LSC 
and normal skin epidermis (Fig. 1). Consistent with previous studies, we also found 
depletion of CK15-marked KSCs in the basal layer of psoriatic lesions most likely due to 
increased stem cell divisions to fuel epidermal hyperplasia (Fig. 1) (Jia et al., 2016). To 
determine whether decreased DNA hydroxymethylation could affect downstream gene 
expression in psoriasis, we looked at nestin whose expression has been previously shown 
to be negatively regulated by TET2 in melanoma (Gomes et al., 2016). Interestingly, the 
reciprocal relationship between 5-hmC and nestin is also seen in psoriasis where loss of 
5-hmC resulted in upregulation of nestin expression in basal and suprabasal keratinocytes 
(Fig. 1). Furthermore, recent studies have shown that nestin expression positively 
correlates with neural stem cell proliferation and negatively correlates with cell 
differentiation (Cui et al., 2012). Thus, the hyperproliferation and aberrant differentiation 
of keratinocytes in psoriasis could be associated with overexpression of nestin. These 
findings suggest that reduction of 5-hmC levels in psoriatic KSCs could disrupt stem cell 
homeostasis and promote psoriasis pathogenesis. 
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Figure 1: Immunofluorescence analysis of 5-hmC in KSCs of human psoriasis, LSC, 
and normal skin. The dotted lines mark the junction between the epidermis (top) and the 
dermis (bottom) of skin. Basal and suprabasal keratinocytes in psoriasis exhibit marked 
reduction in nuclear 5-hmC levels compared to that of LSC and normal skin. CK15-
marked KSCs are confined to the epidermal rete ridges and show loss of cytoplasmic 
CK15 expression in psoriasis (arrow and inset). Nestin expression in the cytoplasm is 
markedly increased in the psoriatic epidermis compared to LSC and normal skin (note 
dermal vessel positive controls, V = blood vessels). 
 
Clinical psoriasis samples show excessive expansion of TA cell compartment with 
loss of 5-hmC 
Epidermal hyperplasia due to keratinocyte hyperproliferation in psoriasis is a 
result of increased asymmetrical KSC divisions into TA cells (Jia et al., 2016). In 
psoriatic lesions, we found that with a loss of CK15-marked KSCs there was an 
upregulation of TA cell marker, FABP5, in the suprabasal epidermal layer (Fig. 3) 
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(Watarai et al., 2013). Depletion of the CK15-expressing KSC pool and expansion of the 
FABP5-labeled TA cell compartment was not exhibited in either LSC or normal skin 
(Fig. 3). A schematic drawing in Figure 2 diagrams the predicted populations of KSCs, 
TA cells, and terminally differentiated cells (TDCs) in psoriasis versus LSC. The 
FABP5-labeled psoriatic TA cells also exhibited markedly reduced levels of 5-hmC 
compared to controls, which suggests differential epigenetic regulation (Fig. 3). Taken 
together, these multiplex IF studies of clinical psoriasis showed reduced 
hydroxymethylation in both KSCs and progenitor TA cells in psoriatic lesions. 
 
 
Figure 2: Schematic drawing of cell populations in psoriasis and LSC. Psoriatic 
lesions show expansion of the FABP5-labeled TA cell population and reduction of the 
CK15-labeled KSCs as well as the TDC population. On the other hand, LSC seems to 
show expansion of the KSC and TDR cell populations with fewer TA cells. 
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Figure 3: Immunofluorescence analysis of 5-hmC in TA cells of human psoriasis, 
LSC, and normal skin. The dotted lines mark the junction between the epidermis (top) 
and the dermis (bottom) of skin. There is marked upregulation of cytoplasmic and nuclear 
FABP5 expression in keratinocytes discretely localized in the suprabasal layer of 
psoriatic epidermis. These FABP5-labeled TA cells in psoriasis also exhibit loss of 
nuclear 5-hmC, which is not seen in the suprabasal keratinocytes of LSC and normal 
skin.
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Imiquimod-induced psoriasis mouse model confirms loss of 5-hmC with 
downregulation of TET expression 
The imiquimod (IMQ)-induced psoriasis mouse model is now a widely used 
model for human psoriasis (van der Fits et al., 2009). In this study, C57BL/6J mice were 
treated topically with 62.5μg of Aldara 5% cream daily onto their shaved back and ears 
for six consecutive days. After six days of treatment, the mouse skin exhibited signs of 
erythema, scaling, and thickening (Fig. 4). Hematoxylin and eosin staining of the lesional 
tissue revealed epidermal features that resembled human psoriasis including: acanthosis, 
parakeratosis, and prominence of superficial dermal microvessels (Fig. 4) (Boehncke & 
Schön, 2015; Jia et al., 2016). Immunohistochemical (IHC) stains and multiplex labeling 
approaches showed that IMQ-treated lesions had lower 5-hmC levels and higher nestin 
expression in comparison to the untreated mouse skin (Fig. 4). Furthermore, pathological 
hyperproliferation of keratinocytes is also seen with a loss of CK15-labeled KSCs and 
increased FABP5-labeled TA cells in the IMQ-treated skin (Fig.4). In summary, our 
findings in IMQ-treated mice were similar to our results in clinical psoriasis.  
Quantitative real-time PCR was performed specifically on mouse epithelium 
(dermal components excluded) to determine whether IMQ treatment changed gene 
expression. TET1 and TET2 expression was reduced in IMQ-treated skin with TET1 
showing more significant loss of expression (Fig. 5). Decreased TET expression was 
consistent with lower 5-hmC levels as seen in the IHC stains of treated mice (Fig. 4). 
There was also a significant increase in nestin expression in the treated mice, which 
aligns with our IHC findings and confirms the inverse correlation between 5-hmC and 
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nestin (Fig. 5,4) (Gomes et al., 2016). These RT-PCR trends aligned with preliminary 
findings of TET2 and nestin expression in human psoriasis (Appendix 1). Our results 
suggest that decreased TET expression after IMQ treatment in mice could lead to loss of 
5-hmC in psoriatic lesions, and raised questions regarding the role of TET enzyme 
pathways in stem cell dysregulation in human psoriatic lesions.   
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Figure 4: Immunohistochemical analysis of imiquimod induced psoriasis mouse 
model. The dotted lines mark the junction between the epidermis (top) and the dermis 
(bottom) of skin. IMQ-treated psoriatic mouse epidermis exhibit marked reduction in 
nuclear 5-hmC levels in comparison to untreated control skin (note internal dermal 
positive controls). Psoriatic lesions also show marked upregulation of cytoplasmic nestin 
expression in both the epidermal and dermal compartments compared to control (S= 
sebaceous lobule). Multiplex stains highlight the inverse correlation between 5-hmC 
levels and nestin expression. Dispersed CK15-positive epidermal cells (encircled) in 
control skin exhibit low 5-hmC but are absent within psoriatic lesions (inset shows CK15 
and 5-hmC positive cells in bulge regions of adjacent hair follicles). 5-hmC and FABP5 
double labeling reveals strong FABP5 expression within sebaceous lobules (arrows) of 
control skin that is not present in the control epidermis. Marked FABP5 expression is 
seen in the cytoplasm and nucleus of suprabasal keratinocytes of IMQ-treated epidermis. 
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Figure 5: Quantitative real-time PCR of epidermal samples from IMQ-treated 
mouse skin versus untreated mouse skin. IMQ-treated mouse epidermis exhibit 
downregulation of TET1 and TET2 expression and upregulation of nestin expression 
compared to untreated mouse epidermis. Statistically significant differences are indicated 
as ** P<0.01, ***P<0.001 by Student’s t-test. Data are shown as mean ± SEM of three 
biological replicates (n=3). 
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Genome-wide mapping of 5-hmC in the epithelium of IMQ-treated mice reveals 
loci-specific loss of 5-hmC in psoriatic lesions 
To investigate whether reduction of 5-hmC levels in psoriasis is genome-wide or 
loci-specific, we conducted genome-wide mapping of 5-hmC in IMQ-treated mice to 
compare IMQ-induced epidermal lesions with untreated epidermis. We used a barcoded 
hydroxymethylated DNA immunoprecipitation assay coupled with deep sequencing 
(hMeDIP-seq) to quantitatively compare 5-hmC tag densities at specific genome loci 
between treated and untreated mouse skin. Genomic tag density analysis revealed 
insignificant difference in global 5-hmC levels between treated and untreated epidermal 
samples (Fig. 6). However, there were significantly lower 5-hmC levels in both CpG 
islands and genebodies of IMQ-treated epidermis (Fig. 6). We identified a total of 364 
differentially hydroxymethylated genes when comparing IMQ-treated skin to untreated 
skin (2X fold change, MaxTags≥ 50). 271 of these genes exhibited significantly lower 5-
hmC levels and 93 of these genes had significantly higher 5-hmC levels. Thus, these 
findings support a loci-specific reduction of 5-hmC in the psoriatic mouse epidermis.
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Figure 6: Genome-wide mapping of 5-hmC via hMeDIP-seq in epidermal samples 
from IMQ-treated mouse skin versus untreated mouse skin. Data analyzed from 2 
biological replicates (n=2). IMQ-treated mouse epidermis and untreated epidermis do not 
show significant difference in global 5-hmC levels. However, there is reduced 5-hmC 
levels in CpG islands and genebodies of IMQ-treated epidermis compared to untreated 
control. 
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Gene ontology (GO) analysis provided insight into how these differentially 
hydroxymethylated genes affect different biological systems (Fig. 7). This analysis 
reports enrichment scores for biological pathways calculated from p-values based on 
enrichment of hydroxymethylated genes in a particular GO annotation (log10(p-value). 
The GO analysis results showed that downregulated genes in IMQ-treated epidermis 
decreased chromosome condensation, regulation of the canonical Wnt signaling 
pathways, and regulation of cell differentiation (enrichment scores, -11.19, -4.04, -1.86, 
respectively). 
 
Figure 7: Gene Ontology analysis of hMeDIP-seq data showing pathways influenced 
by downregulated genes. GO terms of pathways downregulated in IMQ-treated 
epidermis compared to untreated control. 
 
Ingenuity Pathway Analysis (IPA) of the differentially hydroxymethylated genes 
also revealed involvement in pathways associated with stem cell homeostasis such as 
RAR activation (P=2.80x10-3) and Wnt/β-catenin signaling (P=5.28x10-3) (Fig. 8, 
Appendix 2,3) (Lee et al., 2009; Veltri, Lang, & Lien, 2018). Significant loss of 5-hmC 
can be seen in the Akt1 gene, which is a key player in both the RAR and Wnt/β-catenin 
pathways (Fig. 8, Appendix 2,3). MAPKAPK2, which is downstream of Akt1 in the RAR 
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pathway, also exhibited significant loss of 5-hmC (Fig. 8, Appendix 2). Differential 
hydroxymethylation of another key player in regulating stem cell homeostasis, Notch1, is 
also revealed through hMeDIP analysis (Fig. 8)(Okuyama, Tagami, & Aiba, 2008). IPA 
analysis also built network diagrams with differentially hydroxymethylated genes within 
the NFκB, ERK1/2, and PI3K pathways (Fig. 9). Taken together, genome-wide mapping 
of 5-hmC revealed that loci-specific reduction of hydroxymethylation could disrupt 
downstream genes regulating stem cell homeostasis, which is crucial during psoriasis 
pathogenesis.  
 
 
Figure 8: Ingenuity Pathway Analysis of hMeDIP-seq data. Top 10 statistically 
significant canonical pathways identified by IPA through analysis of 364 differentially 
hydroxymethylated genes is shown here. hMeDIP results for Akt1, MAPKPAK2, and 
Notch1 shown with peaks correlating to 5-hmC levels (Log2Ratio WT treated/control:     
-1.282, -1.121, -1.336, respectively). 
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Figure 9: IPA network analysis of hMeDIP-seq data. In the network analysis of 
NFκB, ERK1/2, and PI3K pathways, a significant network centered on the gene was 
returned. Green color indicates decreased measurement of 5-hmC and red color shows 
increased 5-hmC. Solid lines indicate direct interaction and dotted lines show indirect 
interaction.
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In vitro restoration of TET expression in KSC calcium proliferation and 
differentiation assay suggests 5-hmC regulation of stem cell homeostasis 
To determine whether 5-hmC plays a role in regulating KSC proliferation and 
differentiation, we performed a calcium-induced proliferation and differentiation assay on 
normal human KSCs in vitro (Hennings et al., 1980). KSCs cultured in normal calcium 
medium (1.5mM) exhibited a differentiating status with hemidesmosome formation, 
normal stratification, and cornification (Fig.10). On the other hand, KSCs cultured in low 
calcium (0.06mM) maintained a proliferative status with independent hyperplasic cells 
lacking stratification or cornification even after 72 hours of incubation (Fig.10). These 
keratinocytes in low calcium cultures exhibited aberrant differentiation, which is 
characteristic of psoriatic keratinocytes.  
Immunofluorescence studies of these human KSC cultures showed reduced 5-
hmC levels in low calcium cultures compared to normal calcium cultures (Fig.11). We 
wondered if altering 5-hmC levels could change KSC proliferation and differentiation 
status in vitro. In order to modulate 5-hmC levels, we treated cultures with vitamin C to 
increase TET expression and promote DNA hydroxymethylation. Induction of TET 
expression via vitamin C treatment has been successfully done in retinal pigment 
epithelial cells as well as melanoma cells (Gustafson et al., 2015; Sant et al., 2018). After 
treating low calcium cultures with vitamin C (200μM) for 48 hours, the keratinocytes 
exhibited increased 5-hmC levels with a more normal differentiation status similar to that 
of keratinocytes in normal calcium cultures (Fig. 11). With restored 5-hmC levels, these 
keratinocytes showed reduced nestin expression, which is a marker for differentiation 
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(Fig. 11)(Cui et al., 2012). Quantitative real-time PCR confirmed our IF findings showing 
a decreasing trend in nestin expression upon restoration of TET expression through 
vitamin C treatment in low calcium cultures (Fig. 12). Thus, 5-hmC likely influences 
downstream genes that are important in restoring KSC homeostasis. 
 
 
Figure 10: Human KSC differentiation and proliferation calcium assay. Human 
KSCs cultured in normal calcium (1.5mM) show normal stratification and cornification, 
whereas KSCs in low calcium (0.06mM) lacked stratification and cornification even after 
72 hours incubation. Low calcium cultures treated with vitamin C show more normal 
stratification and cornification. 
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Figure 11: Immunofluorescence analysis of human KSCs in calcium cultures treated 
with vitamin C suggests 5-hmC regulation of KSCs in vitro. Low 5-hmC levels in the 
nuclei of low calcium KSCs can be rescued via vitamin C treatment to 5-hmC levels 
closer to that of normal calcium KSCs (arrows show positive nuclear 5-hmC staining 
among background cytoplasmic staining). Upon restoration of 5-hmC, low calcium KSCs 
exhibit decreased nestin expression, which again supports the reciprocal relationship 
between 5-hmC and nestin. 
 
 28 
 
Figure 12: Quantitative real-time PCR of human KSCs in calcium cultures. KSC 
culture RT-PCR shows increasing trend in TET2 expression and confirms decreasing 
trend in nestin expression after vitamin C treatment. Statistically significant differences 
are indicated as * P<0.05, ** P<0.01, ***P<0.001 by Student’s t-test. Data are shown as 
mean ± SEM of three biological replicates (n=3). 
 
In vitro restoration of TET expression modulates IL-17R in KSCs 
Since psoriasis is largely immune-mediated, we wondered if altering TET 
expression could also modulate KSC expression of a key player in the psoriatic 
inflammatory response, IL-17R. We used quantitative real-time PCR to look at IL-17R 
expression levels in the normal calcium, low calcium, and vitamin C treated low calcium 
KSC cultures. With decreased TET2 expression in low calcium cultures, IL-17R 
expression in the KSCs increased compared to normal calcium cultures (Fig.13). The 
proliferative status of KSCs induced by low calcium seemed to increase expression of IL-
17R as seen in both human psoriatic lesions and IMQ-treated mouse epidermis (Fig.13). 
Upon restoration of TET expression via vitamin C treatment, the IL-17R expression 
levels returned back down to levels seen in normal calcium. Thus, TET expression may 
also modulate immune responses that play a crucial role during psoriasis pathogenesis. 
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Figure 13: Quantitative real-time PCR of IL-17RA expression in human KSC 
cultures, human psoriasis, and IMQ-induced psoriasis in mice. Measuring IL-17RA 
expression levels is equivalent to IL-17R expression levels. RT-PCR analysis reveals 
high IL-17RA expression and low TET2 expression in human psoriasis, IMQ-treated 
mouse epidermis, and low calcium KSCs in comparison to normal controls. IL-17RA 
expression in low calcium KSCs can be reduced back to IL-17RA levels in normal 
calcium KSCs after induced TET enzyme expression via vitamin C treatment. 
Statistically significant differences are indicated as * P<0.05, ** P<0.01, ***P<0.001 by 
Student’s t-test. Data are shown as mean ± SEM of three biological replicates (n=3). 
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DISCUSSION 
 
 In this study, we for the first time show significant loss of 5-hmC in epidermal 
KSCs and TA cells of psoriatic lesions. This altered hydroxymethylation landscape could 
modulate KSC gene expression that manifests as keratinocyte hyperproliferation and 
aberrant differentiation during psoriasis pathogenesis. Our IF stains showed that the 
capacity of KSC self-renewal was also affected as CK15-marked KSCs were depleted, 
while the FABP5-marked TA cell compartment expanded significantly in both human 
psoriasis samples and IMQ-treated mice. Quantitative real-time PCR from both human 
psoriasis and IMQ-treated mouse lesions revealed diminished TET2 expression, which 
provides an explanation for the loss of 5-hmC levels seen in our immunohistochemical 
stains.  
Recent advancements in hMeDIP-seq technology have allowed us to investigate 
the genome-wide 5-hmC landscape in the psoriatic epidermis of IMQ-treated mice. 
Analysis of the hMeDIP-seq results revealed most significant loci-specific changes in 
DNA hydroxymethylation of genes important in the RAR and Wnt/β-catenin pathways. 
Interestingly, both of these pathways have been shown to play a crucial role in regulating 
stem cell differentiation and proliferation (Lee et al., 2009; Veltri et al., 2018). Induction 
of TET expression via vitamin C treatment of human KSC cultures in calcium assays 
further confirmed the importance of DNA hydroxymethylation in keratinocyte 
differentiation and proliferation. Upon restoration of 5-hmC levels in low calcium 
cultures, the KSCs began to exhibit a more normal differentiation status with formation 
of hemidesmosomes and stratification.  
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In addition, changes in the expression of a key proinflammatory molecule in 
psoriasis, IL-17R, is briefly explored in this study. Human psoriatic lesions, IMQ-treated 
mouse epidermis, and low calcium KSC cultures showed increase in IL-17R expression. 
However, IL-17R expression is reduced back down to normal levels after induced TET 
expression in low calcium KSC cultures. Furthermore, evidence of 5-hmC regulation on 
gene expression is also demonstrated by the reciprocal relationship between 5-hmC and 
nestin that is maintained after vitamin C treatment. Thus, loss of 5-hmC seems to 
characterize psoriatic epidermis and can further modulate downstream gene expression 
important in regulating stem cell homeostasis.  
Many of the histopathological characteristics of psoriasis are due to the disruption 
of KSC homeostasis including parakeratosis, hypogranulosis, acanthosis, and downward 
expansion of the rete ridges (Boehncke & Schön, 2015; Jia et al., 2016; Watarai et al., 
2013; Weatherhead et al., 2011). The multifactorial etiology for psoriasis pathogenesis 
could be in part due to the complexity of KSC crosstalk with many cellular components 
including proinflammatory elements. In particular, the IL-17/IL-23 axis is essential to 
psoriasis pathogenesis where an antagonist against IL-17A or IL-17RA can reverse 
clinical, histological, and molecular characteristics of human psoriatic disease (Blauvelt 
& Chiricozzi, 2018; Leonardi et al., 2012; Papp et al., 2012; van der Fits et al., 2009). 
Psoriasis pathogenesis is seen upon IL-23 injection in wild-type mice, but not in IL-17 
knockout mice (Rizzo et al., 2011). Studies have shown marked elevation of IL-17 in the 
keratinocyte gene set within psoriatic lesions as well as residual expression in treated 
lesions (Clark, 2011; Suárez-Fariñas, Fuentes-Duculan, Lowes, & Krueger, 2011). 
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Persistent IL-17 expression in treated lesions could be an explanation for the recurrent 
nature of psoriasis commonly at the same affected sites (Clark, 2011). The IL-17 
signaling pathway has also been shown to control keratinocyte proliferation via the p63-
mediated TRAF4-ERK5 axis (Wu et al., 2015). Real-time PCR analysis of our KSC 
calcium culture assays show that high IL-17R expression in low calcium cultures can be 
reverted to normal levels in keratinocytes upon induced TET expression via vitamin C 
treatment. This suggests that by increasing DNA hydroxymethylation, it is possible to 
repress a proinflammatory cytokine receptor that is essential for the pathogenesis of 
psoriatic disease. However, there are limitations to using vitamin C treatment as a means 
of modulating TET expression since vitamin C is known to have a plethora of effects on 
the cell. Further mechanistic studies along with more specific ways of manipulating TET 
enzymes will be necessary to better understand how 5-hmC can modulate IL-17R levels. 
Confirmation in TET knockout mice will be needed to determine if these findings will 
also hold true in vivo. 
 Crosstalk between KSCs and TA cells has also been shown to induce KSC 
proliferation (Hsu et al., 2014). With increased asymmetrical stem cell divisions and 
expansion of the TA cell compartment in psoriasis, we wondered if DNA 
hydroxymethylation could modulate stem cell homeostasis in promoting a psoriatic 
disease state. Studies have found high expression of TET in embryonic stem cells with 
TET1 and TET2 knockout mice exhibiting a reduction in pluripotency-related gene 
expression (Ficz et al., 2011). Furthermore, restoration of TET expression in somatic 
cells allowed for reprogramming of cells into induced pluripotent stem cells (Kohli & 
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Zhang, 2013). Maintenance of DNA hydroxymethylation via TET was also found to be 
critical in regulating hematopoietic stem cell self-renewal and differentiation (Kohli & 
Zhang, 2013). In this present study, we found decreased TET2 expression in psoriatic 
epidermis compared to normal skin. With loss of 5-hmC levels, this could result in the 
loss of KSC self-renewal capacities as stem cells increasingly undergo asymmetric cell 
divisions to become TA cells at the expense of the KSC population seen in our IF studies 
(Jia et al., 2016). Furthermore, the reciprocal relationship between 5-hmC levels and 
nestin expression suggests that DNA hydroxymethylation has significant influence on 
downstream gene expression that could be important in regulating keratinocyte 
differentiation. Taken together, these findings show that 5-hmC could play a crucial role 
in modulating gene expression involved maintaining stem cell homeostasis. 
Even though studies have demonstrated the importance of 5-hmC within the DNA 
demethylation pathway, it is still relatively understudied in psoriasis in comparison to 
DNA methylation. Genome-wide investigation of methylation profiles in psoriasis 
showed increased methylation in lesional skin with differentially methylated genes 
contributing to the pathogenesis of psoriasis (P. Zhang et al., 2010; Zhou et al., 2016). 
Furthermore, studies were able to associate differentially methylated genes with several 
histological features of psoriasis including: elongated rete ridges, Munro’s microabscess, 
and focal hypergranulosis (Chandra et al., 2018). Successful phototherapy treatment of 
psoriatic lesions not only exhibited reversal of histopathological features in psoriasis, but 
also showed genomic alteration to a more normal DNA methylation landscape (Gu et al., 
2015; Ozkanli et al., 2015). Importantly, 5-hmC has been shown to arise mainly from 
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pre-existing 5-mC, which emphasizes the dynamic balance of genomic methylation and 
hydroxymethylation necessary to maintain normal gene expression (Ficz et al., 2011). 
This present study offers a new perspective through the establishment of the 5-hmC 
landscapes in human psoriatic epidermis and in the epithelium of IMQ-induced mouse 
psoriasis model (van der Fits et al., 2009).  
Genome-wide characterization of the 5-hmC profile in IMQ-treated mouse 
epidermis compared to untreated epidermis through hMeDIP-seq analysis confirmed loss 
of 5-hmC within CpG islands and genebodies. Analysis of the differentially 
hydroxymethylated genes in IMQ-treated skin showed that this list included Akt1, 
MAPKPK2, and Notch1 which have been shown to maintain stem cell homeostasis 
(Schwermann et al., 2009; Segrelles et al., 2014; M. Zhang & Zhang, 2019). Loss of 
hydroxymethylation and modulation of Akt1 expression could lead to aberrant regulation 
of stem cell activation and proliferation in relation to the PI3K/Akt signaling pathway 
(Segrelles et al., 2014; M. Zhang & Zhang, 2019). Downstream of Akt1, MAPKAPK2 
has been shown to be associated with hematopoietic stem cell renewal as well as 
inflammatory responses during cutaneous wound healing (Schwermann et al., 2009; 
Thuraisingam et al., 2010). Both Akt1 and MAPKAPK2 are part of the RAR activation 
pathway that regulates keratinocyte proliferation (Appendix 2)(Gericke et al., 2013; Lee 
et al., 2009). Notch1 is usually highly expressed in normal epidermis, but reduction in 
Notch1 levels in psoriasis significantly increases the number of proliferative layers in the 
epidermis (Okuyama et al., 2008). The Notch signaling pathway regulates of number of 
processes including cell fate decision, proliferation, differentiation, and apoptosis 
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(Okuyama et al., 2008). This pathway also represses the Wnt/β-catenin pathway, which 
could be related to the downregulation of genes associated with regulating the canonical 
Wnt signaling pathway seen in our GO analysis data (Okuyama et al., 2008). The Wnt 
signaling pathway is important in the maintenance of tissue homeostasis and contributes 
to the aberrant regulation of KSCs in psoriatic lesions (Gudjonsson et al., 2010; Veltri et 
al., 2018; Yanfei Zhang et al., 2015). Wnt5a, a key regulator of epidermal differentiation, 
showed residual expression and did not return to baseline levels even after successful 
treatment and resolution of the psoriatic epidermal reaction (Suárez-Fariñas et al., 2011). 
This likely contributes to the recurrent nature of psoriasis at sites that had been resolved 
through successful treatment. Thus, hMeDIP-seq analysis reveals that induction of 
psoriatic disease via IMQ treatment led to changes in DNA hydroxymethylation of genes 
that could disrupt stem cell homeostasis and promote a psoriatic disease state. To validate 
the findings in this study, wild-type untreated mice can also be sent for hMeDIP-seq as a 
baseline to control for systemic effects of IMQ treatment. Further studies in TET 
knockout mice would provide even more insight into TET function and regulation of 
downstream genes. However, when analyzing this genomic data it is also important to 
keep in mind the limitations of using the IMQ-induced psoriasis mouse model in terms of 
translatability to human psoriasis (Hawkes, Gudjonsson, & Ward, 2017) 
hMeDIP-seq also identified other pathways affected by differentially 
hydroxymethylated genes including p38 MAPK and NFκB that can promote psoriasis 
pathogenesis through induction of proinflammatory immune responses. Defects in the 
MAPK pathway cascades of p38 and ERK1/2 have been shown to induce augmented 
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expression of proinflammatory cytokines (Mavropoulos et al., 2013). The NFκB pathway 
also regulates essential inflammatory pathways creating a psoriatic milieu that can alter 
keratinocyte behavior (Goldminz, Au, Kim, Gottlieb, & Lizzul, 2013). Studies show a 
positive correlation between severity of epidermal hyperplasia and nuclear expression of 
NFκB (Moorchung et al., 2014). Furthermore, TNFα can modulate gene expression via 
the NFκB pathway. Interestingly, synergistic effects of IL-17A cytokines and TNFα 
induce a gene signature similar to that of psoriatic keratinocytes (Chiricozzi et al., 2011). 
These studies support our hypothesis that aberrant DNA hydroxymethylation could alter 
keratinocyte immune responses driving psoriasis pathogenesis. 
This present study demonstrates that reduction in epidermal 5-hmC is a unique 
epigenetic drift in psoriasis that is not characteristic of other psoriasiform dermatitis such 
as lichen simplex chronicus. The current strategy for diagnosing psoriasis relies heavily 
on differentiating clinical and histopathological features from other psoriasiform 
dermatitis. This study suggests that anti-5-hmC staining could be a promising tool in the 
development of a new diagnostic assay for more accurate psoriasis diagnosis. Further 
studies investigating other psoriasiform dermatitis and varying stages of psoriasis 
pathogenesis would be required to determine the practicality of using 5-hmC loss as a 
marker for psoriasis.  
A recent study investigated TET2-mediated 5-hmC in psoriatic tissue and found 
an increase in 5-hmC levels (Wang et al., 2018). The discrepancy between the molecular 
findings in their study versus ours is most likely because they analyzed both epidermal 
and dermal compartments of psoriatic tissue, the latter often harboring increased 5-hmC 
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in a variety of inflammatory settings. On the other hand, we separated these 
compartments and looked specifically at the epidermis to study KSCs and TA cells. 
Hydroxymethylation profiles can differ significantly between cell types, which is seen in 
our IF and IHC stains where the dermis exhibits relatively high levels of 5-hmC 
compared to the epidermis in psoriasis. Therefore, inclusion of the dermis in their 
analyses probably skewed their results toward higher overall 5-hmC levels in psoriasis.  
In summary, this study establishes the 5-hmC profile in psoriatic KSCs and TA 
cells and provides a foundation for future functional studies of DNA hydroxymethylation 
in psoriasis. We show that TET-mediated loss of 5-hmC can alter downstream gene 
expression important in maintaining stem cell homeostasis. Importantly, we demonstrate 
that vitamin C treatment can epigenetically reprogram KSCs to exhibit more normal TET 
enzyme expression and 5-hmC levels in vitro. Upon restoration of 5-hmC, we also saw 
morphological changes of KSCs in culture to more normal stratification and 
cornification. Taken together, this study demonstrates the importance of DNA 
hydroxymethylation in psoriasis pathogenesis and suggests a new potential target for 
epigenetic psoriasis therapy.  
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APPENDIX 
 
 
 
Appendix 1: Quantitative real-time PCR of epidermal samples from normal human 
skin versus human psoriatic lesions. Human psoriasis exhibits downregulation of TET2 
expression and upregulation of nestin expression compared to normal skin. Statistically 
significant differences are indicated as ** P<0.01, ***P<0.001 by Student’s t-test. Data 
are shown as mean ± SEM of three biological replicates (n=3). 
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Appendix 2: RAR pathway showing differentially hydroxymethylated genes in 
IMQ-treated mouse epidermis compared to untreated epidermis. IPA generated 
pathway diagram of the most significantly affected canonical pathway. Green color 
indicates decreased measurement of 5-hmC. Solid lines indicate direct interaction and 
dotted lines show indirect interaction. 
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Appendix 3: Wnt Canonical Pathway showing differentially hydroxymethylated 
genes in IMQ-treated mouse epidermis compared to untreated epidermis. IPA 
generated pathway diagram of the second most significantly affected canonical pathway. 
Green color indicates decreased measurement of 5-hmC. Solid lines indicate direct 
interaction and dotted lines show indirect interaction. 
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